
Atenolol by Zyntex is a high-purity cardioselective beta-1 adrenergic receptor blocker (CAS 29122-68-7). It is a fundamental active pharmaceutical ingredient (API) used to manage hypertension, angina pectoris, and cardiac arrhythmias by reducing the workload on the heart.
Exceptional cardioselectivity and a well-established clinical history provide a major advantage in blood pressure regulation. Atenolol works by inhibiting the response to adrenergic stimuli, making it a “gold standard” in the manufacturing of maintenance therapy for chronic hypertension. It helps clinical teams lower the risk of cardiovascular morbidity and mortality. For instance, it is a primary component in producing treatments for cardiac arrhythmias and the prevention of post-myocardial infarction events. Consequently, it enhances patient outcomes through stable heart rate control. As a result, Zyntex ensures high crystalline purity and strictly controlled impurity profiles for our supply. This ensures maximum therapeutic efficacy and safety in your manufacturing cycles.
Moreover, Zyntex supplies high-grade Atenolol for the generic and specialized pharmaceutical industries. This compound acts as a critical agent in managing angina pectoris by decreasing myocardial oxygen demand. It pushes the boundaries of heart-health management by offering a predictable pharmacokinetic profile. At the same time, it serves as a versatile active for combination products, often paired with diuretics like Chlorthalidone. In short, our product serves as a dependable “cardiac workload regulator.” It supports both the high-volume production needs of global supply chains and the precision requirements of innovative drug delivery research.
Recently, scientific interest in Atenolol regarding its application in specialized veterinary cardiology and its role in comparative bioequivalence studies has grown. It provides high efficacy even in once-daily dosing regimens. Because of this, Zyntex offers specialized particle sizes with verified chemical profiles to meet USP, EP, and BP pharmacopeia standards. These formats suit modern high-speed tablet compression and wet granulation processes. Ultimately, choosing Zyntex secures a reliable and transparent pharmaceutical supply chain. We balance adrenergic chemistry expertise with rigorous batch-to-batch HPLC and moisture monitoring. To conclude, our commitment ensures your manufacturing processes achieve the highest levels of performance and stability.
This essential beta-blocker is vital in these four sectors:
Standard treatment for lowering blood pressure. Thus, it is a cornerstone of essential medicine lists for cardiovascular care.
Used to reduce the frequency and severity of chest pain. Consequently, it is vital for products targeting chronic ischemic heart disease.
Primary API for solid dosage forms like tablets. Undoubtedly, it is essential for large-scale retail pharmaceutical production.
Acts as a reference standard in beta-adrenergic studies. Specifically, it supports the development of next-generation selective blockers.
| Parameter | Standard Value |
|---|---|
| Product Name | Atenolol |
| Molecular Formula | $C_{14}H_{22}N_{2}O_{3}$ |
| Molecular Weight | 266.34 g/mol |
| CAS Number | 29122-68-7 |
⚠️ Safety & Handling: Atenolol is a potent API and should only be handled in a professional pharmaceutical facility. Therefore, use adequate local exhaust ventilation and wear appropriate PPE (lab coat, nitrile gloves, safety goggles). Avoid inhalation of dust. Store in a cool, dry place in tightly sealed containers, protected from light and moisture to maintain its chemical potency[cite: 20].